Sugar Balance Formula (Allergy Research Group) – enzyme contamination (2013)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Allergy Research Group Sugar Balance Formula, dietary Supplement, Hypoallergenic, 90 vegetarian capsules. Formulated exclusively for: Allergy Research Group; Alameda, CA 94502.
Brand
Allergy Research Group
Lot Codes / Batch Numbers
Product number 75660, Lot number 0613057, Expiration: August 2015.
Products Sold
Product number 75660, Lot number 0613057; Expiration: August 2015.
Allergy Research Group is recalling Allergy Research Group Sugar Balance Formula, dietary Supplement, Hypoallergenic, 90 vegetarian cap due to Firm was notified by their contract manufacturer that a voluntary recall had been issued by the raw material supplier because certain cellulase enzym. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Firm was notified by their contract manufacturer that a voluntary recall had been issued by the raw material supplier because certain cellulase enzymes have been found to be contaminated with Chloramphenicol.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
AZ, CA, FL, GA, IL, NV, NH, NY
Page updated: Jan 6, 2026